Search Results for ''

published presentations and documents on DocSlides.

Approach to TIA and Management of Stroke after 4.5 hours
Approach to TIA and Management of Stroke after 4.5 hours
by briana-ranney
Approach to TIA and Management of Stroke after 4....
Rethinking TIA  and Minor Stroke
Rethinking TIA and Minor Stroke
by molly
S. Claiborne Johnston, MD, PhD. Dell Medical Schoo...
Welcome to the TIA Clinic
Welcome to the TIA Clinic
by elise
Preventing stroke. Primary prevention & lifest...
Can we safely discharge TIA patients?
Can we safely discharge TIA patients?
by min-jolicoeur
Louis Muller. EM Registrar. January 2010. Objecti...
Stroke & TIA SAPMEA PROJECT ECHO | Neurology SERIES
Stroke & TIA SAPMEA PROJECT ECHO | Neurology SERIES
by adia
Stroke Resources for health Professionals. Stroke ...
Ontario Triage Algorithm for Stroke Prevention Clinic Referrals
Ontario Triage Algorithm for Stroke Prevention Clinic Referrals
by amber
Patients with TIA or Non Disabling Stroke Symptoms...
 Stroke and TIA Evaluations in Neurologically Underserved Regions
Stroke and TIA Evaluations in Neurologically Underserved Regions
by tatiana-dople
Ganesh Asaithambi, MD. John . Nasseff. Neuroscie...
Update from education  committee
Update from education committee
by mastervisa
Train the trainer—content reviewed from. Transie...
Recognizing Stroke  FAST
Recognizing Stroke FAST
by celsa-spraggs
:. F. ace . A. rms . S. peech . T. ime. You an...
Risk Factor Modification Post Stroke
Risk Factor Modification Post Stroke
by olivia-moreira
Ron Pellegrino, MD. November 20, 2015. Objectives...
Screening for Cognitive Impairment in Stroke and TIA
Screening for Cognitive Impairment in Stroke and TIA
by celsa-spraggs
. October 2013. Acknowledgements. Rebecca Fleck,...
Recognizing Stroke  FAST
Recognizing Stroke FAST
by stefany-barnette
:. F. ace . A. rms . S. peech . T. ime. You an...
Stroke Services for London
Stroke Services for London
by maisie
Rachel Tyndall SROPresentation to OSC 4 February 2...
Ticagrelor ADDED to aspirin in Acute NON-SEVERE ISCHEMIC Stroke OR TIA OF ATHEROSCLEROTIC
Ticagrelor ADDED to aspirin in Acute NON-SEVERE ISCHEMIC Stroke OR TIA OF ATHEROSCLEROTIC
by eloise
ORIGIN. Pierre . Amarenco. , Hans . Denison. , . S...
Addressing Patients with Cryptogenic Stroke
Addressing Patients with Cryptogenic Stroke
by williams
Epidemiology, Pathophysiology, Diagnosis and Follo...
PREVENTION OF STROKE
PREVENTION OF STROKE
by harmony
-24- Primary prevention refers to those activiti...
Risk of stroke and transient
Risk of stroke and transient
by shepherd
ischaemic. attack in patients with. a diagnosis o...
6 th  May, 2022, 10.30am
6 th May, 2022, 10.30am
by Shadowlord
European Stroke Organisation Conference, Lyon. Gui...
Cost effectiveness of AF monitoring strategies in a
Cost effectiveness of AF monitoring strategies in a
by wang
post-stroke population. Lauren E. . Cipriano. Jeff...
Neurology What not to miss in the ER
Neurology What not to miss in the ER
by melody
Danielle . Pirrie. CCPA. Toronto East General Hos...
Pharmacologic Profiles  of Approved and Investigational Oral
Pharmacologic Profiles of Approved and Investigational Oral
by kinohear
Anticoagulants.  . Warfarin. Dabigatran. Rivaroxa...
ASRH Site Visit Presentation Template
ASRH Site Visit Presentation Template
by stefany-barnette
Use this template to build your presentation for ...
Assessment Tools in Stroke and Transient Ischaemic Attack (TIA) Dr Dwa
Assessment Tools in Stroke and Transient Ischaemic Attack (TIA) Dr Dwa
by lindy-dunigan
1 dwai_sen@yahoo.com Stroke and Transient ischemi...
Antiplatelet
Antiplatelet
by kittie-lecroy
Therapy for the Secondary Prevention of . Cerebr...
Antiplatelet
Antiplatelet
by sherrill-nordquist
Therapy for the Secondary Prevention of . Cerebr...
X- VeRT CV death, stroke/TIA, non-CNS systemic embolism, or MI: 0.51% of the
X- VeRT CV death, stroke/TIA, non-CNS systemic embolism, or MI: 0.51% of the
by LittleMissPerfect
rivaroxaban. group vs. 1.02% of the vitamin K ant...
 IMPACT- AFib : An 80,000 Person Randomized Trial Using the
IMPACT- AFib : An 80,000 Person Randomized Trial Using the
by celsa-spraggs
FDA Sentinel System Platform . Richard Platt, MD,...
Kalani R Wells, APRN, MSN, ACNP-BC, CNRN
Kalani R Wells, APRN, MSN, ACNP-BC, CNRN
by pamella-moone
Neurologic Associates, Ltd.. AANN Neuroscience Nu...